Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis

BACKGROUND: Mucosal sites are hypothesized to play a role in the development of rheumatoid arthritis (RA). Since serum anti-peptidylarginine deiminase (PAD)4 antibodies, including a subset that cross-react with PAD3 (PAD3/4), are specific for RA and associate with severe disease, we sought to examin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arthritis Res Ther
Hoofdauteurs: Demoruelle, M. Kristen, Wang, Hong, Davis, Ryan L., Visser, Ashley, Hoang, Johnny, Norris, Jill M., Holers, V. Michael, Deane, Kevin D., Darrah, Erika
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2021
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8182933/
https://ncbi.nlm.nih.gov/pubmed/34092252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02528-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items